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Abstract
Background: Lung cancer is relatively resistant to radiation treatment and radiation pneumonitis
is a major obstacle to increasing the radiation dose. We previously showed that Caffeic acid
phenethyl ester (CAPE) induces apoptosis and increases radiosensitivity in lung cancer. To
determine whether CAPE, an antioxidant and an inhibitor of NF-kappa B, could be a useful adjuvant
agent for lung cancer treatment, we examine the effects of CAPE on irradiated normal lung tissue
in this study.
Methods: We compared the effects of CAPE on cytotoxicity and intracellular oxidative stress in
normal lung fibroblast and a lung cancer cell line. For in vivo analysis, whole thorax radiation (single
dose 10 Gy and 20 Gy) was delivered to BALB/c male mice with or without CAPE pretreatment.
NF- kappaB activation and the expression levels of acute inflammatory cytokines were evaluated in
mice after irradiation.
Results: The in vitro studies showed that CAPE cause no significant cytotoxicity in normal lung as
compared to lung cancer cells. This is probably due to the differential effect on the expression of
NF-kappa B between normal and malignant lung cells. The results from in vivo study showed that
CAPE treatment decreased the expression of inflammatory cytokines including IL-1 alpha and beta,
IL-6, TNF-alpha and TGF- beta, after irradiation. Moreover, histological and immunochemical data
revealed that CAPE decreased radiation- induced interstitial pneumonitis and TGF-beta
expression.
Conclusion: This study suggests that CAPE decreases the cascade of inflammatory responses
induced by thoracic irradiation without causing toxicity in normal lung tissue. This provides a
rationale for combining CAPE and thoracic radiotherapy for lung cancer treatment in further
clinical studies.
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Background
Lung cancer is the leading cause of cancer death world-
wide. Radiotherapy is an important modality of cancer
treatment. Because radiation pneumonitis is a major
obstacle to increasing the radiation dose, it is important to
determine how the incidence of radiation- induced com-
plication might be decreased and how the dose that nor-
mal lung can tolerate might be increased. Caffeic acid
phenethyl ester (CAPE) is a phenolic antioxidant, an
active anti-inflammatory component of propolis [1-3].
Several studies and our previous study have shown that
the compound elicits several interesting biological func-
tions including inducing apoptosis in various tumor cell
types and anti-inflammatory properties [4-6]. Since reac-
tive oxygen species (ROS) is the major mediators for radi-
ation induced damage [7], a treatment combining
radiation with an antioxidant might provide a strategy for
preventing radiation injury to normal tissues [8]. Various
investigators have demonstrated that radiation-induced
proinflammatory cytokines contributed significant com-
plications associated with radiotherapy [9,10]. Early
manipulation of inflammatory responses could be useful
in modifying subsequent late effect [14]. CAPE is an active
anti-inflammatory compound [11,12], and a specific
inhibitor of the transcription factor nuclear factor-κB (NF-
κB) [13,14]. It might play a role in protecting normal tis-
sue against damage from radiation treatment. However,
the actual effects of CAPE on irradiated normal lung and
the underlying mechanisms of protection are still unclear.
An initial goal of our study was to assess the capacity of
CAPE to decrease radiation pneumonitis. We utilized two
cell lines, normal lung fibroblast (WI-38) and lung cancer
cells (A549), to compare the effects of CAPE on normal
and malignant lung cells in the presence and absence of
radiation treatments in vitro. We were specifically inter-
ested in evaluating the effects of CAPE on the intracellular
ROS and NF-κB activation in these cells. Another impor-
tant goal of this study was to evaluate the efficiency of
CAPE in an animal model of radiation- induced pneumo-
nitis.
Methods
Human lung cancer A549 cell and human normal lung
fibroblast WI-38 cells were obtained from ATCC. They
were routinely cultured in complete MEM medium and
maintained in a 37°C incubator with 5% CO2 and 95%
air.
Cell growth curve analysis with radiation
Exponentially growing cells were treated with or without
CAPE 6 µg/ml for 1 h prior irradiation. Cells were irradi-
ated (9 Gy in a single fraction) with a 6 MeV electron
beam generated by a linear accelerator at a dose rate of
300 cGy/min. After irradiation, the cells were allowed to
grow in the incubator. Viable cells were counted on day 2,
4, 6 and 8 after treatment.
Intracellular H2O2 and glutathione (GSH) analysis
Intracellular H2O2 was assayed with a fluoresence dye,
DCFH-DA, using a FACS caliber flow cytometery, as
described previously [15]. To determine the intracellular
GSH, we performed a colorimetric assay using ApoAlert
glutathione detection kit (Clontech, CA). Cells were lysed
and monochlorobimane was added to the lysate at 37°C
for at least 15 min. The fluorescence intensity was meas-
ured in a plate reader at 395 nm.
Electrophoretic mobility gel shift assays to analyze the 
binding activity of NF-κB
The cells were treated with nuclear extraction reagent 4
hour after 9 Gy irradiation (Pierce, Rockford, IL). The
nuclear proteins from BALB/c mice lung tissues were col-
lected 12 hours after a 20 Gy irradiation. Four murine
lung tissues from each group were checked. The protein
content was measured by the Bradford method. The DNA
oligonucleotides used for NF-κB binding were 5'-TTGTT-
ACAAGGGACT TTCCG TGGGGACTTTCC AGGGAGGC
GTGG-3' for human and 5'- AGTTGAGGGACTT
TCCCAGGC-3' for mouse. Nuclear extracts were incu-
bated with the biotin labeled DNA probe for 20 min at
room temperature. The DNA- protein complex was sepa-
rated from free oligonucleotide on a 5% polyacrylamide
gel. After electrophoresis, the DNA-protein complex was
transferred to a nylon membrane and cross-linked with
UV. The membrane was incubated with streptavidin-
horseradish peroxidase-conjugate and detected by ECL
(Pierce, Rockford, IL).
Mice, radiation and CAPE treatment
Male BABL/c mice between 6 and 8 weeks old were pur-
chased from the Animal Center of the National Science
Council, Taipei, Taiwan. The protocol of animal experi-
mentation was approved by the Chang Gung Memorial
Hospital Experimental Animal Committee. For lung irra-
diation, anesthetized mice were restrained in modified
Perspex tubes. The whole thorax was irradiated by 6 MV X-
ray from a linear accelerator and a 1.5 cm bolus on the
surface. Control mice were subjected to sham-irradiation.
The mice were divided into four groups: control, CAPE
alone, irradiation, irradiation with CAPE treatment. To
analyze NF-κB activation and the expression of inflamma-
tory cytokines, 24 mice were irradiated with 20 Gy and
sacrificed at the indicated times. For histological examina-
tion, 12 mice received 10 Gy irradiation. The mice were
injected intraperitoneally with CAPE (10 mg/kg, solubi-
lized in saline containing 20% Tween 20) 30 min before
irradiation and once a day for 10 days after irradiation.BMC Cancer 2005, 5:158 http://www.biomedcentral.com/1471-2407/5/158
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The expressions of inflammatory cytokines analyzed by 
RNase protection assay (RPA) and real time RT-PCR
The mice were killed 6 hours and 24 hours after 20 Gy
irradiation and RNA was extracted. Four mice from each
group were sacrified at the indicated times and the lungs
were dissected. Total cellular RNA was isolated using Tri-
zol (Gibco, Grand Island, NY) reagents for RPA and real
time RT PCR. Two probe sets-mck2b and mck3b
(Pharmingen, San Diego, CA) were used for RPA. The
biotin-labeled probes (Ambion, Austin, TX) were hybrid-
ized to the target mRNA. The samples were mixed with
loading buffer and separated on a 9% sequencing gel by
electrophoresis. The intensity of each gene was normal-
ized against with L32 and GAPDH expression. Two µg
RNA was subjected to reverse transcription using the
superscript II kit (Invitrogen, Carlsbad, CA) with random
primer to obtain the first cDNA strand. Primers for IL-1 α/
β, IL-6, TNF-α, TGF-β were used for PCR analysis (Applied
Biosystems, Foster, CA). To allow for loading differences,
a GAPDH primer was used as control. Optimized PCR was
performed on an iCycler iQ multicolor real time PCR
detection system. Significant PCR fluorescent signals were
normalized to a PCR fluorescent signal obtained from the
mean value for sham-irradiated control mice.
Histologic and immunochemical staining analysis for 
pulmonary inflammation
Treated and control mice were sacrificed by cervical dislo-
cation at 3 and 12 weeks after 10 Gy irradiation. Three
mice for each group were used. The whole lungs were per-
fused via the trachea before they were removed; they were
fixed in formalin after removal. For histologic analysis,
the lobes were fixed in 10% buffered formalin; paraffin-
embedded and sectioned at an average thickness of 5 µm.
The mounted sections were subjected to H&E and immu-
nochemical staining. They were incubated overnight with
goat anti- mouse TGF-β1antibody (Santa Cruz, CA) After
three wash with PBS, the sections were incubated with
biotinylated anti-goat IgG followed by peroxidase-avidin
staining, washed again in PBS, and treated with 3-amino-
9 ethylcarbazole solution as a chromogen. The specimens
were counterstaining with hematoxylin. Omission of the
primary antibody was used as a negative control, and
murine bowel tissue was used as a positive control for the
presence of TGF-β1.
Results
CAPE causes no cytotoxicity or radiosensitization in 
normal lung cells
In our previous report, we demonstrated that 6 µg/ml
CAPE caused significant cytotoxicity and increased apop-
tosis in lung cancer cells [5]. However, the percentage
apoptosis showed no obvious increase in WI-38 after
CAPE treatment (data not shown). To compare the effects
of CAPE in lung cancer and normal lung cells, we treated
The growth curves of A549 lung cancer cells and WI-38 cells  in the presence of CAPE and irradiation Figure 1
The growth curves of A549 lung cancer cells and WI-38 cells 
in the presence of CAPE and irradiation. Exponentially grow-
ing cells were treated with or without 6 µg/ml CAPE for 1 h 
prior to irradiation. Viable cells were counted on day 2, 4, 6 
and 8 after treatment. The growth curves were obtained by 
plotting the number of viable cells as a function of time in cul-
ture for 8 days. (a) Growth curves of A549 cancer cells; (b) 
Growth curves of WI-38 cells. CAPE significantly reduces in 
vitro cell growth of A549 with or without irradiation, while 
no inhibition of growth was detected in WI-38 cells. Three 
independent experiments were performed for these curves. 
Y axis represents the relative cell count, normalized to the 
cell numbers on Day 0. * P < 0.05, day 4, 6 and 8, CAPE 
treated cells verse CAPE- untreated cells.
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the cells with 6 µg/ml CAPE for 1 hour prior to radiation
and evaluated the cytotoxicity and radiosensitizing effects.
As shown in Figure 1, CAPE had no cytotoxicity and radi-
osensitization effects on WI-38 normal lung cells, in con-
trast to A549 lung cancer cells.
The CAPE- induced decrease of intracellular GSH
described in our previous study might have contributed
the radiosensitization effect on A549. To explore the pos-
sible mechanisms responsible for differential radiosensiti-
zation in A549 and WI-38, the intracellular H2O2 and
GSH were measured after CAPE treatment. The antioxi-
dant effect of CAPE decreased the intracellular H2O2
within 1 h in WI-38 cells (Fig. 2A), as found in A549 cells
in our previous study. However, CAPE did not decrease
the intracellular GSH level in WI-38 cells as it does in
A549 lung cancer cells (Fig. 2B). This differential effect
could explain, at least in part, why CAPE- induced radio-
sensitization is found in A549 but not WI-38.
CAPE attenuates NF-κB expressiondifferentially in normal 
lung and lung cancer cells
CAPE is a specific inhibitor of NF- κB that works by inhib-
iting the interaction of the transcription factor with DNA.
The putative target genes of NF- κB are mainly involved in
immune and inflammatory responses. To demonstrate
the activation of NF- κB after CAPE treatment, gel shift
experiments were conducted in both cell lines (A549 lung
cancer cell line and WI-38 normal lung cell) and in mouse
lung tissue following various treatments. As shown in Fig-
ure 3A and 3B, the nuclear binding of NF-κB is higher in
lung cancer cells than in normal lung cells, and 6 µg/ml
CAPE treatment significantly decreased binding in lung
cancer cells as compared with normal lung cells. Irradia-
tion increased the nuclear binding of NF-κB in both lung
cancer cells and normal lung cells. Pre-treatment with 6
µg/ml CAPE for 1 h decreased the augmentation of NF-κB
binding activity by irradiation in both cell types. Figure 3C
demonstrates the similarity between the nuclear proteins
obtained from murine lung tissues and WI-38. There was
not change in NF-κB binding in unirradiated lung tissues
after CAPE treatment. Irradiation with 20 Gy promoted
NF-κB binding, and treatment with CAPE attenuated this
effect 12 h after irradiation. The results clearly showed that
irradiation activates NF- κB binding and the activation is
attenuated by CAPE.
Effect of CAPE on the radiation- induced expression of 
proinflammatory cytokines as revealed by RPA and real- 
time PCR
We used a non-radioactive ribonuclease protection assay
to screen the expressions of various cytokines mRNAs. The
mRNAs detected were for cytokines involved in acute
inflammation and the fibrosis of pneumonitis: TNF-α/β,
IL-6, IFN-β/γ, IL-6, IL-10, IL-1α/β, IL12 and MIF. These
Intracellular peroxide and glutathione content of WI-38 cells Figure 2
Intracellular peroxide and glutathione content of WI-38 cells. 
Determination of peroxides and GSH in intact cells (WI-38 
control cells or cell treated with CAPE) was accomplished by 
fluorescence measurement as described in the Materials and 
Methods section. (a) Intracellular H2O2 levels. (b) intracellu-
lar GSH levels. Data are presented as the mean ± SE of three 
separate experiments. Y axis represents the relative fluores-
cence, normalized to the fluorescence value of control cells. 
* P < 0.05, CAPE treated cells verse CAPE- untreated cells.
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cytokine mRNAs were barely detectable in control but the
levels were elevated after 20 Gy pulmonary irradiation.
After combined radiation and CAPE treatment, there was
a decrease in the trend towards overexpression of TNF-α,
IL-6, IL-1α/β and TGF-β mRNA (data not show). Further-
more, we quantified the expression of these cytokines
after radiation and CAPE treatment by real-time RT-PCR.
Effects of CAPE treatment on radiation-induced increases in  inflammatory cytokine mRNA levels in vivo Figure 4
Effects of CAPE treatment on radiation-induced increases in 
inflammatory cytokine mRNA levels in vivo. The TGF-β, TNF-
α, IL-1α/βand IL-6 mRNA levels (a) 6 hours (b) 24 hours 
after20 Gy irradiation. The results are expressed as RNA 
ratio. The RNA ratio was determined from the mRNA level 
at indicated time after treatment to control for a specific 
gene. Data are the mean ± SE. * P < 0.05, CAPE-treated irra-
diated mice versus CAPE-untreated irradiated mice.
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Inhibition of irradiation- induced activation of DNA binding  of NF-κB by CAPE in vitro and in vivo Figure 3
Inhibition of irradiation- induced activation of DNA binding 
of NF-κB by CAPE in vitro and in vivo. Nuclear extracts were 
isolated and mobility gel shift assays were performed as 
described in the Material and Methods Section. Representa-
tive figures are ahown for (a) A549 cancer cells; (b) WI-38 
cells 4 hours after 9 Gy irradiation; and (c) normal mice lung 
12 hours after 20 Gy irradiation. These demonstrate the 
binding activity of nuclear NF-κB is higher in A549 cancer 
cells. CAPE inhibited the binding activity of NF-κB in A549 
cancer cells with or without irradiation and in normal lung 
cells after irradiation.
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Low expression levels were noted in unirradiated BALB/c
mice and there were no obvious changes after 10 mg/kg
CAPE treatment. Irradiation (20 Gy) induced a significant
increase in TNF-α, IL-6, IL-1α/β and TGF-β mRNA 6 hours
and 24 hours after irradiation (Fig. 4A and 4B). The atten-
uating effect of CAPE measured by RPA was quantified by
real-time PCR. At 6 hours, CAPE treatment reduced the
increase in the levels of the TNF-α, IL-1α and TGF-β
mRNA by half (p < 0.05 verse irradiated untreated mice),
and IL-6 and IL-1β mRNA by one quarter. The inhibitory
effect of CAPE on IL-6 and IL-1β mRNA levels were more
significant 24 h after irradiation (p < 0.05 verse irradiated
untreated mice).
CAPE attenuates the induction of pulmonary 
inflammation by irradiation
No lesions were observed in non-irradiated lung from
control mice. Microscopic examination of the lungs 3
weeks after 10 Gy irradiation revealed an increase in acute
inflammatory infiltrate in the interstitium. After CAPE
treatment, the degree of interstitial pneumonitis 3 weeks
after 10 Gy irradiation was less pronounced (Fig 5A–C).
Similar changes persisted 12 weeks after irradiation (Fig
5D–F).
Immunochemical analysis showed that unirradiated lung
tissue exhibited very low TGF-β1 immunoreactivity in the
Histologic analyses with H&E staining on irradiated murine lung tissue Figure 5
Histologic analyses with H&E staining on irradiated murine lung tissue. Three mice from each group were checked. Represent-
ative slides are shown for (a) unirradiated control mice at 3 weeks after sham-irradiation; (b) untreated mice at 3 weeks after 
10 Gy irradiation; (c) CAPE-treated mice at 3 week after irradiation 10 Gy irradiation; (d) unirradiated control mice at 12 
weeks after sham-irradiation; (e) untreated mice at 12 weeks after 10 Gy irradiation; (f) CAPE-treated mice at 12 week after 
irradiation 10 Gy irradiation. These demonstrate that interstitial pneumonia with increased acute inflammatory infiltrate in the 
interstitium was detected at 3 weeks and 12 weeks after irradiation. CAPE treatment attenuated the extent of inflammation. 
Magnification × 200
(a) (b) (c)
1
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parenchyma and muscularis propria. By 3 weeks after 10
Gy irradiation, positive TGF-β1 staining had increased.
CAPE treatment attenuated the radiation- induced
increase. (Fig 6)
Discussion
In this study, CAPE cause no significant cytotoxicity and
radiosensitization in normal lung cell, in contrast to that
noted in lung cancer cells. CAPE is a potent and specific
inhibitor of activation of nuclear transcription factor NF-
κB [12]. NF-κB activation could induce compensated
mechanisms and decrease apoptosis. The inhibition of
NF-κB by CAPE is a possible mechanism for tumor cell
cytotoxicity [16-18]. We found significant higher expres-
sion of NF-κB binding in lung cancer cells than normal
lung cells. CAPE significantly decreased the NF-κB bind-
ing activity in lung cancer cells. In contrast, it caused no
significant change in the expression of NF-κB binding in
normal lung. The differential downregulation of NF-κB by
CAPE might explain why CAPE caused significant cytotox-
icity and growth inhibition in lung cancer cells but not
normal lung cells. Furthermore, we found that CAPE had
a radiosensitizating effect on lung cancer cells but not on
normal lung cells. The mechanism underpinning this
radiosensitization may be related to intracellular ROS,
GSH and NF-κB [19-21] and it needs further investiga-
tion. Intracellular GSH might play a role because we noted
that GSH levels decrease after CAPE treatment in tumor
cells but not in normal lung cells. GSH decreases radia-
tion-induced damage through its function as a free radical
scavenger. A high concentration of intracellular thiol is an
important way to resist cytotoxic and radiation damage in
cancer cells. The depletion of GSH in lung cancer cells is
consisting with the differential radiosensitization
between tumor cells and normal lung cells.
The lung is the major dose-limiting organ for radiother-
apy in thoracic region and radiation pneumonitis is a seri-
ous complication of lung cancer treatment by
radiotherapy. Acute pneumonitis is characterized by
edema, infiltration of inflammatory cells and thickening
of the alveolar septa. Late radiation- induced lung damage
is characterized by pulmonary fibrosis, which is usually
proceeded by fibrosing alveolitis [22]. Franko et al [23]
pointed out the pathomorphological effects in irradiated
lung in relation to the lung function; fibrosis was first
observed 8 weeks post-irradiation at 10.3 Gy and the
number of fibrotic lesions had increased 10- fold by 14
weeks. The response induced by radiation in vivo is associ-
ated with increased expression and activity of inflamma-
tory cytokines. NF-κB is believed to play a pivotal role in
the induction of cytokine expression in inflammatory
response [24,25]. Haase et al [26] reported that DNA
binding by NF-κB is activated for 6 months after irradia-
tion of the rat lung. This might play a role in sustaining
chronic inflammation and hyerproliferation of mesen-
chymal cells after radiation. NF-κB plays a key role in the
induction of these cytokines in vivo. The efficacy of CAPE
in inhibiting NF-κB activation and proinflammatory pro-
duction has been demonstrated [13,14,27,28]. Fitzpatrick
et al [14] reported that CAPE significantly attenuated bac-
terial peptidoglycan polysaccharise-induced colitis and
Immunohistochemical staining with TGF-β antibody on murine lung tissues Figure 6
Immunohistochemical staining with TGF-β antibody on murine lung tissues. Three mice from each group were checked. Repre-
sentative slides are shown for (a) unirradiated control mice at 3 weeks after sham-irradiation; (b) untreated mice at 3 weeks 
after 10 Gy irradiation; (c) CAPE-treated mice at 3 week after irradiation 10 Gy irradiation. These demonstrated that CAPE 
treatment attenuated the increased TGF-β immunoreactivity after irradiation. Magnification × 250.
(a)  (b) (c)
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reduced the inflammatory cytokine level. Linard et al [27]
demonstrated that CAPE treatment reduced the NF-κB
activation and attenuated the increase in IL-6 and IL-1β
expression in intestine. However, there were few reports
about the relationship between CAPE and radiation pneu-
montits. The present study has demonstrated that CAPE
treatment inhibits NF-κB activation and reduces the over-
expression of genes involved in the acute inflammatory
response, including IL-1α/β, TNF-α and IL-6 after irradia-
tion in the mouse lungs. We found that CAPE treatment
inhibited NF-κB activation and reduced the overexpres-
sion of genes involved in the acute inflammatory response
including IL-6 and IL-1β, consistent with the results of
Linard's series. In addition, the finding of the inhibition
of TNF-α and IL-1 by the selective blockade of NF-κB
pathway is similar to observations reported in alveolar
epithelial cells [25,29]. Because these elevated cytokines
are closely related to radiation induced pneumonitis
[30,31], this could explain why CAPE treatment decreased
irradiation-induced interstitial pneumonitis 3 and 12
weeks post-irradiation. Moreover, the results showed
CAPE treatment is effective in reducing the expression of
TGF-β1 after irradiation. TGF-β is a potent chemoattract-
ant for fibroblasts and triggers the expression of extracel-
lular matrix components in pulmonary fibrosis. The
predominant localization of TGF-β in areas of inflamma-
tory cell infiltrates and fibrosis suggests involvement of
this cytokine in the pathogenesis of radiation- induced
pulmonary fibrosis [32,33]. The mechanisms by which
CAPE decreases TGF-β are unclear. It is probably through
the NF-κB dependent pathway [34,35] or a process indi-
rectly related to NF-κB [36,37]. In view of theses studies,
we propose that CAPE treatment reduces radiation-
induced pulmonary inflammation and fibrosis after a
longer follow up time.
In summary, we have shown CAPE plays an important
role in decreasing radiation pneumonitis by inflamma-
tory cytokines, at least in part, without causing significant
cytotoxicity. Based on this observation, CAPE is a promis-
ing adjuvant agent in the radiation treatment of lung can-
cer.
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